Cargando…

Development of an Open Microfluidic Platform for Oocyte One-Stop Vitrification with Cryotop Method

Oocyte vitrification technology is widely used for assisted reproduction and fertility preservation, which requires precise washing sequences and timings of cryoprotectant agents (CPAs) treatment to relieve the osmotic shock to cells. The gold standard Cryotop method is extensively used in oocyte vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Shu, Guo, Chenxi, Jiang, Ze, Wei, Hao-Xiang, Jiang, Xin, Gu, Jingkai, Hai, Zhuo, Wang, Tianren, Liu, Yun-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496857/
https://www.ncbi.nlm.nih.gov/pubmed/36140151
http://dx.doi.org/10.3390/bios12090766
_version_ 1784794373348655104
author Miao, Shu
Guo, Chenxi
Jiang, Ze
Wei, Hao-Xiang
Jiang, Xin
Gu, Jingkai
Hai, Zhuo
Wang, Tianren
Liu, Yun-Hui
author_facet Miao, Shu
Guo, Chenxi
Jiang, Ze
Wei, Hao-Xiang
Jiang, Xin
Gu, Jingkai
Hai, Zhuo
Wang, Tianren
Liu, Yun-Hui
author_sort Miao, Shu
collection PubMed
description Oocyte vitrification technology is widely used for assisted reproduction and fertility preservation, which requires precise washing sequences and timings of cryoprotectant agents (CPAs) treatment to relieve the osmotic shock to cells. The gold standard Cryotop method is extensively used in oocyte vitrification and is currently the most commonly used method in reproductive centers. However, the Cryotop method requires precise and complex manual manipulation by an embryologist, whose proficiency directly determines the effect of vitrification. Therefore, in this study, an automatic microfluidic system consisting of a novel open microfluidic chip and a set of automatic devices was established as a standardized operating protocol to facilitate the conventional manual Cryotop method and minimize the osmotic shock applied to the oocyte. The proposed open microfluidic system could smoothly change the CPA concentration around the oocyte during vitrification pretreatment, and transferred the treated oocyte to the Cryotop with a tiny droplet. The system better conformed to the operating habits of embryologists, whereas the integration of commercialized Cryotop facilitates the subsequent freezing and thawing processes. With standardized operating procedures, our system provides consistent treatment effects for each operation, leading to comparable survival rate, mitochondrial membrane potential (MMP) and reactive oxygen species (ROS) level of oocytes to the manual Cryotop operations. The vitrification platform is the first reported microfluidic system integrating the function of cells transfer from the processing chip, which avoids the risk of cell loss or damage in a manual operation and ensures the sufficient cooling rate during liquid nitrogen ([Formula: see text]) freezing. Our study demonstrates significant potential of the automatic microfluidic approach to serve as a facile and universal solution for the vitrification of various precious cells.
format Online
Article
Text
id pubmed-9496857
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94968572022-09-23 Development of an Open Microfluidic Platform for Oocyte One-Stop Vitrification with Cryotop Method Miao, Shu Guo, Chenxi Jiang, Ze Wei, Hao-Xiang Jiang, Xin Gu, Jingkai Hai, Zhuo Wang, Tianren Liu, Yun-Hui Biosensors (Basel) Article Oocyte vitrification technology is widely used for assisted reproduction and fertility preservation, which requires precise washing sequences and timings of cryoprotectant agents (CPAs) treatment to relieve the osmotic shock to cells. The gold standard Cryotop method is extensively used in oocyte vitrification and is currently the most commonly used method in reproductive centers. However, the Cryotop method requires precise and complex manual manipulation by an embryologist, whose proficiency directly determines the effect of vitrification. Therefore, in this study, an automatic microfluidic system consisting of a novel open microfluidic chip and a set of automatic devices was established as a standardized operating protocol to facilitate the conventional manual Cryotop method and minimize the osmotic shock applied to the oocyte. The proposed open microfluidic system could smoothly change the CPA concentration around the oocyte during vitrification pretreatment, and transferred the treated oocyte to the Cryotop with a tiny droplet. The system better conformed to the operating habits of embryologists, whereas the integration of commercialized Cryotop facilitates the subsequent freezing and thawing processes. With standardized operating procedures, our system provides consistent treatment effects for each operation, leading to comparable survival rate, mitochondrial membrane potential (MMP) and reactive oxygen species (ROS) level of oocytes to the manual Cryotop operations. The vitrification platform is the first reported microfluidic system integrating the function of cells transfer from the processing chip, which avoids the risk of cell loss or damage in a manual operation and ensures the sufficient cooling rate during liquid nitrogen ([Formula: see text]) freezing. Our study demonstrates significant potential of the automatic microfluidic approach to serve as a facile and universal solution for the vitrification of various precious cells. MDPI 2022-09-19 /pmc/articles/PMC9496857/ /pubmed/36140151 http://dx.doi.org/10.3390/bios12090766 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Miao, Shu
Guo, Chenxi
Jiang, Ze
Wei, Hao-Xiang
Jiang, Xin
Gu, Jingkai
Hai, Zhuo
Wang, Tianren
Liu, Yun-Hui
Development of an Open Microfluidic Platform for Oocyte One-Stop Vitrification with Cryotop Method
title Development of an Open Microfluidic Platform for Oocyte One-Stop Vitrification with Cryotop Method
title_full Development of an Open Microfluidic Platform for Oocyte One-Stop Vitrification with Cryotop Method
title_fullStr Development of an Open Microfluidic Platform for Oocyte One-Stop Vitrification with Cryotop Method
title_full_unstemmed Development of an Open Microfluidic Platform for Oocyte One-Stop Vitrification with Cryotop Method
title_short Development of an Open Microfluidic Platform for Oocyte One-Stop Vitrification with Cryotop Method
title_sort development of an open microfluidic platform for oocyte one-stop vitrification with cryotop method
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496857/
https://www.ncbi.nlm.nih.gov/pubmed/36140151
http://dx.doi.org/10.3390/bios12090766
work_keys_str_mv AT miaoshu developmentofanopenmicrofluidicplatformforoocyteonestopvitrificationwithcryotopmethod
AT guochenxi developmentofanopenmicrofluidicplatformforoocyteonestopvitrificationwithcryotopmethod
AT jiangze developmentofanopenmicrofluidicplatformforoocyteonestopvitrificationwithcryotopmethod
AT weihaoxiang developmentofanopenmicrofluidicplatformforoocyteonestopvitrificationwithcryotopmethod
AT jiangxin developmentofanopenmicrofluidicplatformforoocyteonestopvitrificationwithcryotopmethod
AT gujingkai developmentofanopenmicrofluidicplatformforoocyteonestopvitrificationwithcryotopmethod
AT haizhuo developmentofanopenmicrofluidicplatformforoocyteonestopvitrificationwithcryotopmethod
AT wangtianren developmentofanopenmicrofluidicplatformforoocyteonestopvitrificationwithcryotopmethod
AT liuyunhui developmentofanopenmicrofluidicplatformforoocyteonestopvitrificationwithcryotopmethod